Skip to main content

Table 3 Cohort averages and statistical significance results for the wearable metrics

From: A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease)

Mean (Median)

M0-M1

M1-M2

M2-M3

M3-M4

M4-M5

M5-M6

Overall Cohort Mean (Median)

[range]

Wilcoxon p-value

ADM

1171.6 (1063.2)

1183.2 (954.1)

952.0 (893.7)

1094.1 (935.9)

1011.3 (1065.6)

943.5 (811.1)

1059.6 (962.3) [684 to 1625]

0.10

ADS

6902.7 (6452.9)

6850.6 (6867.9)

7825.7 (7068.2)

8431.5 (6525.0)

7317.2 (5955.8)

6346.6 (4971.1)

7253.2 (6526.9) [2532 to 16,315]

0.51

ADE

288.9 (240.8)

264.2 (208.3)

272.8 (236.0)

277.8 (238.4)

260.0 (281.8)

259.5 (246.3)

270.6 (235.8) [125 to 475]

0.80

  1. ADM Average daily maximum, ADS Average daily steps, ADE Average daily steps per 30-min epoch. M month